WeVote

Bill

Bill

PR 26-0558

Vaccine Administration Protection Emergency Declaration Resolution of 2026

26th Council Period (2025-2026) Introduced by Phil Mendelson

DC emergency resolution sought expedited protections for vaccine administration programs. Introduced February 2026, the bill was withdrawn after initial committee review, sugges...

Withdrawn
0
WeVote Research Nonpartisan
Bill Summary · PR 26-0558

Legislative bill overview

Bill PR 26-0558 is a resolution introduced in the District of Columbia Council by Chairman Phil Mendelson that declares an emergency related to vaccine administration protection. The bill was introduced on February 25, 2026, retained by the Committee on Health with comments on March 3, 2026, and subsequently withdrawn on March 4, 2026. The brief legislative history suggests the measure did not advance beyond initial committee review.

Why is this important

Emergency declarations carry procedural significance in legislative bodies, often allowing bills to bypass standard review timelines and receive expedited consideration. A vaccine administration protection emergency declaration would have addressed urgent concerns related to the administration and delivery of vaccines, potentially including healthcare worker safety, vaccine access, or protection against interference with vaccination programs. The rapid withdrawal indicates either resolution of the underlying emergency concern or substantive issues that prevented advancement.

Potential points of contention

Without access to the bill's substantive text, several common areas of contention for vaccine-related legislation include: (1) scope of "protection" and whether it addresses administrative workers, facilities, or the vaccination process itself; (2) questions about whether an emergency declaration was warranted or appropriate; (3) potential concerns raised by the Committee on Health that prompted withdrawal; (4) balance between public health objectives and individual rights or operational flexibility; (5) resource allocation and implementation mechanisms; and (6) whether the measure duplicated existing protections or created new regulatory burdens.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.